Space medicine breakthrough? Kidney and liver tissue bioprinted off Earth for 1st time ever

July 12, 2026 - 18:18

For the first time, scientists have successfully 3D bioprinted human kidney and liver tissue aboard the International Space Station. The experiment, conducted by a team of researchers from the University of California, San Diego, used a specially designed bioprinter that operates in microgravity. The goal is to produce functional organ tissue that could one day be used for transplants or drug testing, without the need for Earth-based manufacturing.

The bioprinter works by layering living cells and a gel-like scaffold into small tissue samples. In zero gravity, the cells can assemble more naturally, forming structures that closely mimic real human organs. The kidney and liver tissues printed in space showed improved cell viability and organization compared to similar samples printed on Earth.

"This mission marks an exciting step forward for in-space biomanufacturing," said Dr. Adam Feinberg, the project's lead researcher. He noted that the lack of gravity allows cells to form more complex three-dimensional structures, which is difficult to achieve on the ground. The tissues were returned to Earth for analysis, and early results suggest they could function better than lab-grown alternatives.

The implications are significant. If the technology advances, it could reduce the shortage of donor organs and provide a more reliable way to test new drugs. It also opens the door for long-duration space missions, where astronauts might one day print replacement tissues or organs on demand. While full-sized organs remain a distant goal, this breakthrough brings space medicine closer to reality.